Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke

Objective: To assess the evidence for the use of diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) in the diagnosis of patients with acute ischemic stroke. Methods: We systematically analyzed the literature from 1966 to January 2008 to address the diagnostic and prognostic value of DWI and PWI. Results and Recommendations: DWI is established as useful and should be considered more useful than noncontrast CT for the diagnosis of acute ischemic stroke within 12 hours of symptom onset. DWI should be performed for the most accurate diagnosis of acute ischemic stroke (Level A); however, the sensitivity of DWI for the diagnosis of ischemic stroke in a general sample of patients with possible acute stroke is not perfect. The diagnostic accuracy of DWI in evaluating cerebral hemorrhage is outside the scope of this guideline. On the basis of Class II and III evidence, baseline DWI volumes probably predict baseline stroke severity in anterior territory stroke (Level B) but possibly do not in vertebrobasilar artery territory stroke (Level C). Baseline DWI lesion volumes probably predict (final) infarct volumes (Level B) and possibly predict early and late clinical outcome measures (Level C). Baseline PWI volumes predict to a lesser degree the baseline stroke severity compared with DWI (Level C). There is insufficient evidence to support or refute the value of PWI in diagnosing acute ischemic stroke (Level U).

[1]  S. Warach,et al.  Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imaging , 2000 .

[2]  Leif Østergaard,et al.  Diffusion and perfusion MR imaging in acute ischemic stroke: a comparison to SPECT , 2001, Comput. Methods Programs Biomed..

[3]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[4]  R Frayne,et al.  Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  H. Jinnah,et al.  Animal models of generalized dystonia , 2005, NeuroRX.

[6]  J. Roder,et al.  Forward genetic screen of mouse reveals dominant missense mutation in the P/Q‐type voltage‐dependent calcium channel, CACNA1A , 2007, Genes, brain, and behavior.

[7]  Adnan I. Qureshi,et al.  Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .

[8]  M E Moseley,et al.  Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome?: A Multivariable Analysis , 2000, Stroke.

[9]  R. von Kummer.  Imaging of Stroke Pathology without Predefined Gold Standard , 2002, Cerebrovascular Diseases.

[10]  S. Warach,et al.  Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.

[11]  B. Buckley,et al.  Audit of a policy of magnetic resonance imaging with diffusion-weighted imaging as first-line neuroimaging for in-patients with clinically suspected acute stroke. , 2003, Clinical radiology.

[12]  L. Østergaard,et al.  Safety and Efficacy of MRI-Based Selection for Recombinant Tissue Plasminogen Activator Treatment: Responder Analysis of Outcome in the 3-Hour Time Window , 2009, Cerebrovascular Diseases.

[13]  L Bozzao,et al.  Acute stroke: usefulness of early CT findings before thrombolytic therapy. , 1997, Radiology.

[14]  C. Fletcher,et al.  Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Werner Hacke,et al.  Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke: Present Status , 2003, Stroke.

[16]  T. Zwingman,et al.  Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies , 2008, Neuroscience.

[17]  M. Luby,et al.  Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison , 2007, The Lancet.

[18]  R. Corominas,et al.  Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene , 2009, Journal of the Neurological Sciences.

[19]  M. Laakso,et al.  Apolipoprotein E Polymorphism and Acute Ischemic Stroke: A Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging Study , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[21]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.

[22]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.

[23]  S M Davis,et al.  Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. , 1999, Stroke.

[24]  Jeffrey L Saver,et al.  Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. , 2009, Stroke.

[25]  Steven Warach,et al.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset , 2006, Stroke.

[26]  E. Hess,et al.  Migraines in Mice? , 1996, Cell.

[27]  W. Hacke,et al.  CT and Diffusion-Weighted MR Imaging in Randomized Order: Diffusion-Weighted Imaging Results in Higher Accuracy and Lower Interrater Variability in the Diagnosis of Hyperacute Ischemic Stroke , 2002, Stroke.

[28]  W Hacke,et al.  Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. , 2000, AJNR. American journal of neuroradiology.

[29]  S. Warach,et al.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.

[30]  Gottfried Schlaug,et al.  Ischemic lesion volumes in acute stroke by diffusion‐weighted magnetic resonance imaging correlate with clinical outcome , 1997, Annals of neurology.

[31]  Zachary D. Tebb.  MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke within and Beyond Established Time Windows: An Analysis of 1210 Patients , 2008 .

[32]  Gereon R Fink,et al.  MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. , 2002, Radiology.

[33]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[34]  H. Ellis.  stroke , 1997, The Lancet.

[35]  Keith Muir,et al.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.

[36]  J. Grotta,et al.  Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. , 2001, JAMA.

[37]  A Gregory Sorensen,et al.  Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. , 2002, AJNR. American journal of neuroradiology.

[38]  S. Warach,et al.  Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. , 2009, Stroke.

[39]  John A Butman,et al.  Comparison of MRI and CT for detection of acute intracerebral hemorrhage. , 2004, JAMA.

[40]  Stroke neuroimaging. , 2003, Stroke.

[41]  G. Cosnard,et al.  Usefulness of Magnetic Resonance-Derived Quantitative Measurements of Cerebral Blood Flow and Volume in Prediction of Infarct Growth in Hyperacute Stroke , 2001, Stroke.

[42]  P. Bossuyt,et al.  BMC Medical Research Methodology , 2002 .

[43]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[44]  T. Bird,et al.  Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. , 2005, Archives of neurology.

[45]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. , 2000, Lancet.

[46]  S. Warach,et al.  Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. , 2000, Annals of neurology.

[47]  A. Jaillard.  Reply to the Paper by von Kummer et al.: Imaging of Stroke Pathology without Predefined Gold Standard , 2002, Cerebrovascular Diseases.

[48]  A. Villringer,et al.  Stroke Magnetic Resonance Imaging Is Accurate in Hyperacute Intracerebral Hemorrhage: A Multicenter Study on the Validity of Stroke Imaging , 2004, Stroke.

[49]  Lee Schwamm,et al.  Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis. , 2009, Stroke.

[50]  S. Warach,et al.  MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe , 2005, Stroke.

[51]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[52]  M. Knauth,et al.  Comparison of CT with diffusion-weighted MRI in patients with hyperacute stroke , 2001, Neuroradiology.

[53]  C. Manelfe,et al.  Early CT Diagnosis of Hemispheric Brain Infarction , 1995, Springer Berlin Heidelberg.

[54]  T. Neumann-Haefelin,et al.  MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows: An Analysis of 1210 Patients , 2007, Stroke.

[55]  E. O. Bregman,et al.  The Present Status. , 1926 .

[56]  G. Schlaug,et al.  Diffusion-weighted imaging and National Institutes of Health Stroke Scale in the acute phase of posterior-circulation stroke. , 2001, Archives of neurology.

[57]  J. Jankovic,et al.  Dystonia in spinocerebellar ataxia type 6 , 2002, Movement disorders : official journal of the Movement Disorder Society.

[58]  H. Jinnah,et al.  Paroxysmal dyskinesias in mice , 2008, Movement disorders : official journal of the Movement Disorder Society.

[59]  G. Gronseth,et al.  Invited Article: Practice parameters and technology assessments , 2008, Neurology.

[60]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[61]  J. Kucharczyk,et al.  Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.

[62]  Brian Silver,et al.  A three-item scale for the early prediction of stroke recovery , 2001, The Lancet.

[63]  P. Lyden,et al.  Thrombolytic therapy for acute stroke--not a moment to lose. , 2008, The New England journal of medicine.

[64]  G. Schlaug,et al.  Is the Association of National Institutes of Health Stroke Scale Scores and Acute Magnetic Resonance Imaging Stroke Volume Equal for Patients With Right- and Left-Hemisphere Ischemic Stroke? , 2002, Stroke.

[65]  Joana,et al.  Neuroimaging , 2002 .

[66]  Scott Hamilton,et al.  Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.